SCHEMBL5082268

SCHEMBL5082268

Cc1c(CN(C)C(=O)C=Cc2cnc3c(c2)CN(C)CC(=O)N3)oc2ccccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5082258 1.00
Hydrochloric Acid SCHEMBL1253087 0.99
Hydrochloric Acid SCHEMBL1253095 0.99
SCHEMBL13408272 0.91
Hydrochloric Acid SCHEMBL1253497 0.91
Hydrochloric Acid SCHEMBL1253495 0.91
SCHEMBL5079749 0.90
SCHEMBL5079748 0.90
Afn-1252 SCHEMBL724936 0.90
Afn-1252 SCHEMBL29378725 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608377-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF FAB I AND FURTHER ANTIBIOTICS AFFINIUM PHARM INC (CA) 2008-10-01 EP claimed